It has been reported that the parkin gene family members (PARK1/4, PARK2, PARK5, PARK6, PARK7, PARK8, PARK9, and PARK15) were overexpressed in the tumors of patients with non-small cell lung cancer (NSCLC) [6]. Here, PRKN is linked to non-small cell lung carcinoma.